Lopera Sarah D, O'Kane Victoria M, Goldhirsh Jessica L, Piper Brian J
Geisinger Commonwealth School of Medicine, Scranton, PA, USA.
Center for Pharmacy Innovation and Outcomes, Scranton, PA, USA.
J Atten Disord. 2023 Oct;27(12):1322-1331. doi: 10.1177/10870547231177467. Epub 2023 Jun 8.
The objectives of this report were to characterize the regional and state differences in prescription methamphetamine and amphetamine distribution in the US.
Prescription methamphetamine and amphetamine distribution was obtained from the Drug Enforcement Administration for 2019.
Total per capita drug weight distribution of amphetamine was 4,000 times higher than methamphetamine. Regionally, total per capita drug weight for methamphetamine was highest in the West (32.2% of total distribution) and lowest in the Northeast (17.4%). The total per capita drug weight for amphetamine was highest in the South (37.0% of total distribution) and lowest in the Northeast (19.4%). Distribution of methamphetamine was 16.1% while amphetamine was 54.0% of its production quota.
Overall, prescription amphetamine distribution was common while prescription methamphetamine distribution was rare. The patterns observed in distribution are likely the result of stigmatization, differences in accessibility, and the efforts of initiatives such as the Montana Meth Project.
本报告的目的是描述美国处方甲基苯丙胺和苯丙胺分布的地区和州差异。
从美国缉毒局获取2019年处方甲基苯丙胺和苯丙胺的分布情况。
苯丙胺的人均药物总重量分布比甲基苯丙胺高4000倍。在地区上，甲基苯丙胺的人均药物总重量在西部最高（占总分布的32.2%），在东北部最低（占17.4%）。苯丙胺的人均药物总重量在南部最高（占总分布的37.0%），在东北部最低（占19.4%）。甲基苯丙胺的分布占其生产配额的16.1%，而苯丙胺为54.0%。
总体而言，处方苯丙胺的分布很常见，而处方甲基苯丙胺的分布很少见。观察到的分布模式可能是污名化、可及性差异以及蒙大拿甲基苯丙胺项目等举措努力的结果。
